Pharmahuasca: human pharmacology of oral DMT plus harmine.
about
Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actionsAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsPharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenineRisk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloidsAcute Biphasic Effects of AyahuascaBehavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.Comparison of the discriminative stimulus effects of dimethyltryptamine with different classes of psychoactive compounds in ratsModification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.The hallucinogenic world of tryptamines: an updated review.Neuropharmacology of N,N-dimethyltryptamineThe psychoactive flora of Papua New Guinea.Pharmacokinetic interactions between monoamine oxidase A inhibitor harmaline and 5-methoxy-N,N-dimethyltryptamine, and the impact of CYP2D6 statusAnalytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.Effects of the Natural β-Carboline Alkaloid Harmine, a Main Constituent of Ayahuasca, in Memory and in the Hippocampus: A Systematic Literature Review of Preclinical Studies.Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Characterization of the synthesis of N,N-dimethyltryptamine by reductive amination using gas chromatography ion trap mass spectrometry.Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances.Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.William Burroughs: Sailor of the Soul.Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine.Candyflipping and Other Combinations: Identifying Drug-Drug Combinations from an Online Forum.: An ancient sacrament for treatment of contemporary psychiatric illness?N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
P2860
Q24633393-6102636A-0D55-408F-AD78-9F665672BA99Q26746137-7479D7EB-792E-44FE-B2B7-B896615A28A6Q28206596-49F25CAF-B931-4A61-A12E-56A14AF4AB72Q28315282-76DA1A60-ABFC-4F96-89FB-CDB74ACA500CQ28548629-0192B3BD-649D-4555-B05E-9E09DE781519Q30358201-ADE9703F-3576-49EF-A525-D1351C1248AAQ33693380-B5986322-8F6A-49CB-93DF-5BDDD6DB5947Q33740814-66152AF5-A498-43A0-9F19-578C1441500EQ33833054-2A76FD65-02B3-4EB8-BF32-007172A5A663Q34087847-CAA40BAB-6ACF-40FE-9216-84B66B4A96C8Q34471834-8BC7E7CE-A260-4FB5-8C68-418781983A6DQ34524116-80768787-12C6-40E5-8318-62303FD78932Q35202063-8DD1D4DB-5422-4A74-A6DF-9A09C11153AAQ36776603-BA546A51-1776-4AD6-94FB-A2D2591DDB55Q38009283-2DC8F31C-C3A4-4FC0-BBA6-85B8A5E135F9Q39029520-1E4F13D9-5C49-454D-9EF6-9551B3C16B6BQ41462770-7A6052DD-0ED0-42C8-B8FE-0767FF82C8CCQ42963079-D9C99846-C8A9-4720-9038-77417EB4A267Q44949973-7E6DD7DE-EAC2-4923-B9C0-96CFCBF45E93Q46950279-398DF805-8C1F-44FB-9A35-FE1E36BA7C22Q47619495-E8B6715F-5179-4EAE-B040-32A3E7DE0B78Q50506127-60BD7990-09FB-4FE5-BCD3-C354077CEB8AQ54992302-3437A623-10F1-40F7-9111-C7441004AF64Q55002999-C4F7D611-20A3-4446-AB95-75E16906ACDDQ56852531-AE2E88F5-EC1B-4455-AF24-5EAF01DC70A5Q57075471-BDF68F3D-3F56-48B0-8EED-4705AA9FF42D
P2860
Pharmahuasca: human pharmacology of oral DMT plus harmine.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@ast
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@en
type
label
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@ast
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@en
prefLabel
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@ast
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@en
P2860
P1476
Pharmahuasca: human pharmacology of oral DMT plus harmine.
@en
P2093
P2860
P304
P356
10.1080/02791072.1999.10471741
P577
1999-04-01T00:00:00Z